Actinium Receives Orphan Drug Designation From FDA for Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients Biotech Investing
Critical Outcome Technologies Completes Private Placement With a Successful U.S. Life Science Investor Biotech Investing
Lattice Biologics and Sunnybrook Research Institute Commence Study to Develop New Cancer Screening Methods Biotech Investing
Advances in Electrophoresis Technology Advancing Global Market, Reports BCC Research Biotech Investing
ContraVir's CMX157 Outperforms Gilead's Tenofovir AF (TAF) Against Hepatitis B Virus in Independent Head-to-Head In-Vitro Study Biotech Investing
Electrophysiology Devices Market to Grow at a CAGR of 5.0% From 2014 to 2020: Grand View Research, Inc. Biotech Investing
Naturally Splendid Updates Development of Coconut/HempOmega Product Line for Cocos Pure Beverage Biotech Investing
5 Top NASDAQ Biotech Stocks: Alexza Pharmaceuticals, Vericel Corporation up Nearly 40 Percent Biotech Investing
BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia A Biotech Investing
SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE Biotech Investing